Skip to main content
TipRanks
Go Ultimate75% OFF

GoodRx Holdings (GDRX) Stock Statistics & Valuation Metrics

1,330 Followers

Total Valuation

GoodRx Holdings has a market cap or net worth of $1.21B. The enterprise value is $1.25B.

Market Cap
$1.21B
Enterprise Value
$1.25B

Share Statistics

GoodRx Holdings has 107,181,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
107,181,200
Owned by Insiders
13.02%
Owned by Institutions
81.87%

Financial Efficiency

GoodRx Holdings’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.03%.

Return on Equity (ROE)
0.05
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
4.03%
Return on Capital Employed (ROCE)
0.08
Revenue Per Employee
1.14M
Profits Per Employee
43.67K
Employee Count
697
Asset Turnover
0.57
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of GoodRx Holdings is 67.68. GoodRx Holdings’s PEG ratio is -1.20.

PE Ratio
67.68
PS Ratio
1.55
PB Ratio
1.87
Price to FCF
8.33
Price to Operating Cash Flow
5.99
PEG Ratio
-1.20

Income Statement

In the last 12 months, GoodRx Holdings had revenue of 796.85M and earned 30.44M in profits. Earnings per share was 0.09.

Revenue
796.85M
Gross Profit
739.26M
Operating Income
87.49M
Pretax Income
56.54M
Net Income
30.44M
EBITDA
184.36M
Earnings Per Share (EPS)
0.09

Cash Flow

In the last 12 months, operating cash flow was 201.58M and capital expenditures -55.84M, giving a free cash flow of 145.75M billion.

Operating Cash Flow
201.58M
Free Cash Flow
145.75M
Free Cash Flow per Share
0.43

Dividends & Yields

GoodRx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
12.00%
Earnings Yield
1.35%

Stock Price Statistics

Beta
1.33
52-Week Price Change
15.96%
50-Day Moving Average
3.44
200-Day Moving Average
2.88
Relative Strength Index (RSI)
52.05
Average Volume (3m)
1.14M

Important Dates

GoodRx Holdings upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Mar 04, 2027
Ex-Dividend Date
―

Financial Position

GoodRx Holdings as a current ratio of 2.61, with Debt / Equity ratio of 88.08%

Current Ratio
2.61
Quick Ratio
2.61
Debt to Market Cap
0.51
Net Debt to EBITDA
1.52
Interest Coverage Ratio
2.05

Taxes

In the past 12 months, GoodRx Holdings has paid 26.10M in taxes.

Income Tax
26.10M
Effective Tax Rate
0.46

Enterprise Valuation

GoodRx Holdings EV to EBITDA ratio is 8.53, with an EV/FCF ratio of 10.00.

EV to Sales
1.86
EV to EBITDA
8.53
EV to Free Cash Flow
10.00
EV to Operating Cash Flow
7.23

Balance Sheet

GoodRx Holdings has $296.11M in cash and marketable securities with $538.95M in debt, giving a net cash position of -$242.84M billion.

Cash & Marketable Securities
$296.11M
Total Debt
$538.95M
Net Cash
-$242.84M
Net Cash Per Share
-$2.27
Tangible Book Value Per Share
$0.06

Margins

Gross margin is 88.05%, with operating margin of 10.25%, and net profit margin of 2.07%.

Gross Margin
88.05%
Operating Margin
10.25%
Pretax Margin
5.27%
Net Profit Margin
2.07%
EBITDA Margin
21.76%
EBIT Margin
10.47%

Analyst Forecast

The average price target for GoodRx Holdings is $3.33, which is 11.43% higher than the current price. The consensus rating is Moderate Sell

Price Target
$3.33
Price Target Upside
6.60% Downside
Analyst Consensus
Moderate Sell
Analyst Count
2
Revenue Growth Forecast
-1.83%
EPS Growth Forecast
-48.77%

Scores

Smart Score
3
AI Score
63